Ratings by Maxim Group (Michael Okunewitch)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/18/2026 VolitionRX VNRX New Coverage Buy
(N/A)
1.37
(1.42)
3.65% Details
5/28/2026 HCW Biologics Inc. HCWB Maintain Buy
(N/A)
 
 
  Details
5/20/2026 Gilead Sciences GILD Upgrade Buy
(Hold)
130.50
(128.26)
-1.72% Details
5/11/2026 Longeveron LGVN Downgrade Hold
(Buy)
0.85
(0.67)
-21.18% Details
5/11/2026 20/20 Biolabs AIDX New Coverage Buy
(N/A)
1.37
(0.63)
-54.01% Details
5/4/2026 FibroBiologics FBLG Downgrade Hold
(Buy)
1.46
(0.86)
-41.1% Details
4/8/2026 NervGen Pharma Corp NGEN Maintain Buy
(N/A)
 
 
  Details
3/6/2026 Mainz Biomed B.V. MYNZ Downgrade Hold
(Buy)
0.81
(0.84)
3.7% Details
2/19/2026 Evaxion Biotech EVAX New Coverage Buy
(N/A)
3.32
(3.54)
6.63% Details
9/23/2025 Citius Oncology Inc. CTOR Upgrade Buy
(Hold)
1.78
(0.70)
-60.67% Details
7/23/2025 Anebulo Pharmaceuticals ANEB Downgrade Hold
(Buy)
1.83
(0.36)
-80.33% Details
5/29/2025 HCW Biologics Inc. HCWB Maintain Buy
(N/A)
 
 
  Details
5/23/2025 Citius Oncology Inc. CTOR Downgrade Hold
(Buy)
0.91
(0.70)
-23.08% Details
5/15/2025 Anebulo Pharmaceuticals ANEB Maintain Buy
(N/A)
 
 
  Details
5/1/2025 Radiopharm Theranostics RADX New Coverage Buy
(N/A)
3.91
(4.35)
11.25% Details
2/20/2025 Chemomab Therapeutics CMMB Maintain Buy
(N/A)
 
 
  Details
2/14/2025 Mainz Biomed B.V. MYNZ New Coverage Buy
(N/A)
6.53
(0.81)
-87.6% Details
11/27/2024 Citius Oncology Inc. CTOR New Coverage Buy
(N/A)
1.00
(0.70)
-30% Details
11/8/2024 Gilead Sciences GILD Maintain
(N/A)
 
 
  Details
10/15/2024 Ocugen, Inc. OCGN New Coverage Buy
(N/A)
0.95
(1.48)
55.79% Details
9/24/2024 FibroBiologics FBLG New Coverage Buy
(N/A)
2.76
(1.46)
-47.1% Details
6/14/2024 Rani Therapeutics Holdsing s RANI New Coverage Buy
(N/A)
4.08
(0.78)
-80.88% Details
5/13/2024 Chemomab Therapeutics CMMB New Coverage Buy
(N/A)
0.84
(2.35)
179.76% Details
12/7/2023 Adamis Pharma DMK New Coverage Buy
(N/A)
0.61
(0.23)
-62.3% Details
9/21/2023 Anebulo Pharmaceuticals ANEB New Coverage Buy
(N/A)
3.48
(0.36)
-89.66% Details
9/12/2023 Irwin Naturals IWINF Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Kiora Pharmaceuticals KPRX Maintain Buy
(N/A)
 
 
  Details
7/21/2023 Lexaria Bioscience LEXX New Coverage Buy
(N/A)
0.76
(0.57)
-25% Details
6/28/2023 BioRestorative Therapies Inc. BRTX Maintain Buy
(N/A)
 
 
  Details
2/9/2023 Kiora Pharmaceuticals KPRX Upgrade Buy
(Hold)
6.94
(2.64)
-61.96% Details
12/22/2022 MediWound Ltd MDWD New Coverage Buy
(N/A)
11.00
(14.73)
33.91% Details
9/28/2022 BioRestorative Therapies Inc. BRTX New Coverage Buy
(N/A)
2.46
(0.40)
-83.74% Details
8/15/2022 Kiora Pharmaceuticals KPRX Downgrade Hold
(Buy)
0.16
(2.64)
1550% Details
3/24/2022 Longeveron LGVN New Coverage Buy
(N/A)
6.52
(0.85)
-86.96% Details
1/19/2022 Kiora Pharmaceuticals KPRX New Coverage Buy
(N/A)
0.80
(2.64)
230% Details